PARTIQoL: Prostate Cancer Quality of Life Research
Contact Information
For more information, please contact Chris Lescinskas at clescinskas@mgh.harvard.edu.
Explore This Research Program
Study Description
The goal of the trial is to study two types of radiation therapy: Intensity Modulated Radiation Therapy (IMRT) and Proton Beam Therapy (PBT). Both treatments are equally effective at killing prostate cancer cells, but each may cause side effects related to the radiation. Scientists have reason to believe that PBT may cause fewer serious side effects than IMRT, but so far research results have been mixed. This study is being done to find out which type of radiation is best for treating prostate cancer and whether there are significant differences in the side effects of each treatment. Our primary endpoint will use patient reports of side effects and general wellbeing two years after completing treatment. This means that your personal experiences will ultimately guide the study’s findings!Participating Sites
Massachusetts General Hospital - Boston, MA
Status: Actively Enrolling
Contact: Jason Efstathiou, MD, DPhil: jefstathiou@partners.org or 617-726-5866
University of Pennsylvania - Philadelphia, PA
Status: Actively Enrolling
Contact: Justin Bekelman, MD: bekelman@uphs.upenn.edu or 215-662-7266
Washington University - St. Louis, MO
Status: Actively Enrolling
Contact: Jeffrey Michalski, MD, MBA: jmichalski@radonc.wustl.edu or 314-362-8566
Northwestern Medicine Chicago Proton Center - Warrenville, IL
Status: Actively Enrolling
Contact: William Hartsell, MD: whartsell@chicagocancer.org or 630-821-6492
University of Washington - Seattle, WA
Status: Actively Enrolling
Contact: Jing Zeng, MD: jzeng13@uw.edu or 206-598-4100
Princeton Radiation Oncology - Somerset, NJ
Status: Actively Enrolling
Contact: Edward Soffen, MD: esoffen@prapa.com or 609-655-5755
Rutgers Cancer Institute of New Jersey - New Brunswick, NJ
Status: Actively Enrolling
Contact: Rahul Parikh, MD: parikhrr@cinj.rutgers.edu or 732-253-3939
Provision Center for Proton Therapy - Knoxville, TN
Status: Actively Enrolling
Contact: J. Ben Wilkinson, MD: ben.wilkinson@provisionproton.com or 865-862-1600
Mayo Clinic - Rochester, MN
Status: Actively Enrolling
Contact: Thomas Pisansky, MD: pisansky.thomas@mayo.edu or 507-284-2511
Maryland Proton Treatment Center - Baltimore, MD
Status: Actively Enrolling
Contact: Mark Mishra, MD: mmishra@umm.edu or 410-328-6080
University of Florida Health Proton Therapy Institute - Jacksonville, FL
Status: Actively Enrolling
Contact: Nancy Mendenhall, MD: menden@shands.ufl.edu or 904-588-1475
University Hospitals - Cleveland, OH
Status: Actively Enrolling
Contact: Rodney Ellis, MD: Rodney.Ellis@UHhospitals.org or 216-286-3903
ClinicalTrials.gov Listing
Find additional information about PARTIQoL at our clinicaltrials.gov posting.
The Prostate Health Education Network
PHEN focuses on helping African American men fight prostate cancer.
Prostate Cancer Foundation
PCF funds prostate cancer research around the world.
Zero – The End of Prostate Cancer
ZERO offers comprehensive support for prostate cancer patients and their families.
Leaders in Proton Therapy
Mass General has the only proton therapy site in all of New England, with two proton therapy centers.
participated in Clinical Trials at the Mass General Cancer Center last year
This helped lead to new knowledge and breakthrough therapies.